![Miguel Sanjuan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Miguel Sanjuan
Corporate Officer/Principal chez
PROVENTION BIO, INC.
Profil
Miguel Sanjuan is currently Chief Executive Officer & Director at Paulex Bio, Inc. and Senior Vice President-Research & Early Development at Provention Bio, Inc. Formerly, Dr. Sanjuan was Vice President & Head-Translational Biology at Gossamer Bio, Inc. Education includes an undergraduate degree from the University of Seville and a doctorate from Universidad Autónoma de Madrid.
Postes actifs de Miguel Sanjuan
| Sociétés | Poste | Début |
|---|---|---|
| PROVENTION BIO, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Miguel Sanjuan
| Sociétés | Poste | Fin |
|---|---|---|
| GOSSAMER BIO, INC. | Corporate Officer/Principal | 01/07/2021 |
Formation de Miguel Sanjuan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Seville
 University of Seville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad Autónoma de Madrid
 Universidad Autónoma de Madrid Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
